Marcaine Injection, Solution
Product Images NDC 0404-9768

The text provides a table showing different types of blocks and the recommended concentrations for using MARCAINE and MARCAINE WITH EPINEPHRINE. It includes information on local infiltration, peripheral nerve block, retrobulbar block, sympathetic block, caudal block, lumbar epidural block, epidural test dose, and dental block. It indicates the appropriate concentrations for each type of block. Additionally, it mentions precautions for specific cases, such as pregnant patients and nonobstetrical surgical procedures. It also advises against the use of multiple-dose vials of MARCAINE and MARCAINE WITH EPINEPHRINE for caudal or epidural anesthesia.*

This is a description of different concentrations of Marcaine (bupivacaine) and Marcaine with Epinephrine in relation to motor function when used for caudal, epidural, or peripheral nerve block procedures. The table provides information on the effects of different concentrations (0.25%, 0.5%, 0.75%) on motor blockade and muscle relaxation for various types of operations. It outlines which concentration is suitable for specific levels of muscle block and relaxation based on the mg/mL concentration. The text also mentions the uses of specific concentrations for certain procedures such as abdominal operations, retrobulbar anesthesia, and obstetrical anesthesia.*

The text contains information about different percentages of solutions for nerve blocks, including their effects on motor block. It also mentions the administration techniques for Marcaíne and Marcaíne with Epinephrine products. Additionally, it discusses the use of these solutions for various surgeries and specifies their application for epidural techniques, excluding obstetrical anesthesia.*

This text provides various examples of drugs associated with Methemoglobinemia, categorized into classes such as Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Specific drug examples in each class include nitric oxide, articaine, cyclophosphamide, dapsone, chloroquine, phenytoin, and more. This information can be valuable for healthcare professionals in identifying potential causes of Methemoglobinemia in patients.*

This text details the various concentrations and packaging sizes for sale. The information includes National Drug Codes (NDC), strengths ranging from 25 mg/10 mL to 125 mg/50 mL, and whether it is a single-dose or multiple-dose vial. The concentrations range from 0.25% to 0.5%, and the labeling specifies the number of vials per tray or carton.*

The text contains information about various medications with different dosages and packaging sizes. These medications come in single-dose vials or multiple-dose vials. The dosages mentioned are 150 mg/30 mL, 250 mg/50 mL, and 75 mg/10 mL. The medications are either labeled as 05% or 075%. Each medication has a unique NDC number for identification and tracking purposes.*

This text provides information about different concentrations of a medication in single-dose and multiple-dose vials. The medication comes in different strengths, such as 25 mg/10mL, 75 mg/30mL, 125 mg/50mL at 0.25% concentration, as well as 50 mg/10mL, 150 mg/30mL, and 250 mg/50mL at 0.5% concentration. Each carton contains a specific number of vials with the indicated dosage per milliliter.*

This text appears to be a description related to a pharmaceutical product. It includes information such as the dosage strength (5%), prescription requirements (RX ONLY), expiration date (mm-dd-yy), and a package identification number (LOT# X0000000X). There are also some characters that seem to be part of a product or brand name (HG), possibly indicating its identity.*